Literature DB >> 20050990

The protective effect of melatonin on methamphetamine-induced calpain-dependent death pathway in human neuroblastoma SH-SY5Y cultured cells.

Wilasinee Suwanjang1, Pansiri Phansuwan-Pujito, Piyarat Govitrapong, Banthit Chetsawang.   

Abstract

Methamphetamine (METH) is a potent psychostimulant drug that may cause neuronal cell degeneration. The underlying mechanisms of METH-induced neuronal toxicity remains poorly understood. In this study, we investigated an important role of calpain-dependent cascades in methamphetamine-induced toxicity in human dopaminergic neuroblastoma SH-SY5Y cultured cell lines. In addition, the protective effect of melatonin against METH-induced calpain-dependent death pathway was also investigated. The results of this study show that METH significantly decreased cell viability and tyrosine hydroxylase phosphorylation in SH-SY5Y cultured cells. Melatonin reversed the toxic effect of METH by inducing cell viability. In addition, melatonin was able to restore the reduction in mitochondrial function and phosphorylation of tyrosine hydroxylase in SH-SY5Y treated cells. An induction of calpain expression and activity but a reduction of calpain inhibitor (calpastatin) protein levels were observed in SH-SY5Y cells treated with METH but these effects were diminished by melatonin. These results implicated calpain-dependent death pathways in the processes of METH-induced toxicity and also indicated that melatonin has the capacity to reverse this toxic effect in SH-SY5Y cultured cells.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 20050990     DOI: 10.1111/j.1600-079X.2009.00731.x

Source DB:  PubMed          Journal:  J Pineal Res        ISSN: 0742-3098            Impact factor:   13.007


  12 in total

1.  PKCδ inhibition enhances tyrosine hydroxylase phosphorylation in mice after methamphetamine treatment.

Authors:  Eun-Joo Shin; Chu Xuan Duong; Xuan-Khanh Thi Nguyen; Guoying Bing; Jae-Hyung Bach; Dae Hun Park; Keiichi Nakayama; Syed F Ali; Anumantha G Kanthasamy; Jean L Cadet; Toshitaka Nabeshima; Hyoung-Chun Kim
Journal:  Neurochem Int       Date:  2011-06-13       Impact factor: 3.921

2.  Methamphetamine acutely inhibits voltage-gated calcium channels but chronically up-regulates L-type channels.

Authors:  Marilou A Andres; Ian M Cooke; Frederick P Bellinger; Marla J Berry; Maribel M Zaporteza; Rachel H Rueli; Stephanie M Barayuga; Linda Chang
Journal:  J Neurochem       Date:  2015-04-30       Impact factor: 5.372

3.  Melatonin Protects Methamphetamine-Induced Neuroinflammation Through NF-κB and Nrf2 Pathways in Glioma Cell Line.

Authors:  Pichaya Jumnongprakhon; Piyarat Govitrapong; Chainarong Tocharus; Decha Pinkaew; Jiraporn Tocharus
Journal:  Neurochem Res       Date:  2015-05-22       Impact factor: 3.996

Review 4.  Melatonin as a neuroprotective agent in the rodent models of Parkinson's disease: is it all set to irrefutable clinical translation?

Authors:  Naveen Kumar Singhal; Garima Srivastava; Sonal Agrawal; Swatantra Kumar Jain; Mahendra Pratap Singh
Journal:  Mol Neurobiol       Date:  2011-12-24       Impact factor: 5.590

5.  Genetic deletion of MT(1) and MT(2) melatonin receptors differentially abrogates the development and expression of methamphetamine-induced locomotor sensitization during the day and the night in C3H/HeN mice.

Authors:  Anthony J Hutchinson; Randall L Hudson; Margarita L Dubocovich
Journal:  J Pineal Res       Date:  2012-06-07       Impact factor: 13.007

6.  Specific calpain inhibition by calpastatin prevents tauopathy and neurodegeneration and restores normal lifespan in tau P301L mice.

Authors:  Mala V Rao; Mary Kate McBrayer; Jabbar Campbell; Asok Kumar; Audrey Hashim; Henry Sershen; Philip H Stavrides; Masuo Ohno; Michael Hutton; Ralph A Nixon
Journal:  J Neurosci       Date:  2014-07-09       Impact factor: 6.167

7.  Role of MT1 melatonin receptors in methamphetamine-induced locomotor sensitization in C57BL/6 mice.

Authors:  Anthony J Hutchinson; Jason Ma; Jiabei Liu; Randall L Hudson; Margarita L Dubocovich
Journal:  Psychopharmacology (Berl)       Date:  2013-08-11       Impact factor: 4.530

8.  Melatonin Protects SH-SY5Y Neuronal Cells Against Methamphetamine-Induced Endoplasmic Reticulum Stress and Apoptotic Cell Death.

Authors:  Pawaris Wongprayoon; Piyarat Govitrapong
Journal:  Neurotox Res       Date:  2016-07-01       Impact factor: 3.911

9.  Neurotoxins: free radical mechanisms and melatonin protection.

Authors:  Russel J Reiter; Lucien C Manchester; Dun-Xian Tan
Journal:  Curr Neuropharmacol       Date:  2010-09       Impact factor: 7.363

10.  Melatonin anticancer effects: review.

Authors:  Giuseppe Di Bella; Fabrizio Mascia; Luciano Gualano; Luigi Di Bella
Journal:  Int J Mol Sci       Date:  2013-01-24       Impact factor: 5.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.